European Journal of Cancer
Volume 46, Issue 13 , Pages 2381-2388 , September 2010

Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: Secondary outcomes of a randomised controlled trial

  • Galina Velikova

      Affiliations

    • St James’s Institute of Oncology, University of Leeds, Cancer Research UK Clinical Centre – Leeds, St James’s University Hospital, Leeds LS9 7TF, United Kingdom
    • Corresponding Author InformationCorresponding author at: St James’s Institute of Oncology, Cancer Research UK Centre, Bexley Wing (Level 4), St James’s University Hospital, Beckett Street, Leeds LS9 7TF, UK. Tel.: +44 0113 2067917; fax: +44 0113 2068512.
    • ,
  • Ada Keding

      Affiliations

    • St James’s Institute of Oncology, University of Leeds, Cancer Research UK Clinical Centre – Leeds, St James’s University Hospital, Leeds LS9 7TF, United Kingdom
    • ,
  • Clare Harley

      Affiliations

    • St James’s Institute of Oncology, University of Leeds, Cancer Research UK Clinical Centre – Leeds, St James’s University Hospital, Leeds LS9 7TF, United Kingdom
    • ,
  • Kim Cocks

      Affiliations

    • Clinical Trials Research Unit, University of Leeds, Clinical Trials Research House, 71–75 Clarendon Road, Leeds LS2 9PH, United Kingdom
    • ,
  • Laura Booth

      Affiliations

    • St James’s Institute of Oncology, University of Leeds, Cancer Research UK Clinical Centre – Leeds, St James’s University Hospital, Leeds LS9 7TF, United Kingdom
    • ,
  • Adam B. Smith

      Affiliations

    • St James’s Institute of Oncology, University of Leeds, Cancer Research UK Clinical Centre – Leeds, St James’s University Hospital, Leeds LS9 7TF, United Kingdom
    • Centre for Health & Social Care, University of Leeds, Leeds LS2 9LJ, United Kingdom
    • ,
  • Penny Wright

      Affiliations

    • St James’s Institute of Oncology, University of Leeds, Cancer Research UK Clinical Centre – Leeds, St James’s University Hospital, Leeds LS9 7TF, United Kingdom
    • ,
  • Peter J. Selby

      Affiliations

    • St James’s Institute of Oncology, University of Leeds, Cancer Research UK Clinical Centre – Leeds, St James’s University Hospital, Leeds LS9 7TF, United Kingdom
    • Joint senior authors.
    • ,
  • Julia M. Brown

      Affiliations

    • Clinical Trials Research Unit, University of Leeds, Clinical Trials Research House, 71–75 Clarendon Road, Leeds LS2 9PH, United Kingdom
    • Joint senior authors.

Received 23 December 2009 ,Revised 26 April 2010 ,Accepted 29 April 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Presented as oral presentation at the NCRI Cancer Conference, Birmingham, UK, 5th–9th October 2009.

PII: S0959-8049(10)00371-0

doi: 10.1016/j.ejca.2010.04.030

European Journal of Cancer
Volume 46, Issue 13 , Pages 2381-2388 , September 2010

Article Tools

* Image Usage & Resolution